![Frontiers | The full range of ophthalmological clinical manifestations in systemic lupus erythematosus Frontiers | The full range of ophthalmological clinical manifestations in systemic lupus erythematosus](https://www.frontiersin.org/files/Articles/1055766/fopht-02-1055766-HTML/image_m/fopht-02-1055766-g001.jpg)
Frontiers | The full range of ophthalmological clinical manifestations in systemic lupus erythematosus
![Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier: Molecular Therapy Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier: Molecular Therapy](https://www.cell.com/cms/attachment/5a95780b-91af-4f74-beb4-44a0f5de3794/fx1_lrg.jpg)
Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier: Molecular Therapy
![Frontiers | Microenvironmental Variations After Blood-Brain Barrier Breakdown in Traumatic Brain Injury Frontiers | Microenvironmental Variations After Blood-Brain Barrier Breakdown in Traumatic Brain Injury](https://www.frontiersin.org/files/Articles/750810/fnmol-14-750810-HTML/image_m/fnmol-14-750810-g001.jpg)
Frontiers | Microenvironmental Variations After Blood-Brain Barrier Breakdown in Traumatic Brain Injury
Privileged Molecules for Protein Binding Identified from NMR-Based Screening | Journal of Medicinal Chemistry
![Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides | Journal of Medicinal Chemistry Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm3009025/asset/images/large/jm-2012-009025_0013.jpeg)
Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides | Journal of Medicinal Chemistry
Recent Advances in the Development of Acetyl-CoA Carboxylase (ACC) Inhibitors for the Treatment of Metabolic Disease | Journal of Medicinal Chemistry
Full article: Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis
![University offers record 6,800-plus scholarships to first-year students | Nebraska Today | University of Nebraska–Lincoln University offers record 6,800-plus scholarships to first-year students | Nebraska Today | University of Nebraska–Lincoln](https://news.unl.edu/sites/default/files/media/20220414-scholarships-nt.jpg)